Skip to content
10-Q

Quarterly Report

SPRING PHARMACEUTICAL GROUP, INC.

0001096906-18-000632

← back to feed
Filed
Nov 13, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Nov 13, 2018 29.84M sh
Capex Q2 2019 · Sep 30, 2018 $68.48K
Capex Q2 2019 · Sep 30, 2017 $2.11M
Cash And Equivalents Q2 2019 · Sep 30, 2018 $31.95M
Cash And Equivalents Q2 2019 · Mar 31, 2018 $25.35M
Cash And Equivalents Q2 2019 · Sep 30, 2017 $19.19M
Cash And Equivalents Q2 2019 · Mar 31, 2017 $10.31M
Stockholders Equity Q2 2019 · Sep 30, 2018 $104.34M
Stockholders Equity Q2 2019 · Mar 31, 2018 $105.11M
Current Liabilities Q2 2019 · Sep 30, 2018 $2.2M
Current Liabilities Q2 2019 · Mar 31, 2018 $1.98M
Current Assets Q2 2019 · Sep 30, 2018 $36.16M
Current Assets Q2 2019 · Mar 31, 2018 $30.07M
Total Assets Q2 2019 · Sep 30, 2018 $109.56M
Total Assets Q2 2019 · Mar 31, 2018 $110.14M
Sga Expense Q2 2019 · Sep 30, 2018 $1.11M
Sga Expense Q2 2019 · Sep 30, 2018 $2.19M
Sga Expense Q2 2019 · Sep 30, 2017 $868.26K
Sga Expense Q2 2019 · Sep 30, 2017 $1.78M
Rd Expense Q2 2019 · Sep 30, 2018 $68.42K
Rd Expense Q2 2019 · Sep 30, 2018 $391.16K
Rd Expense Q2 2019 · Sep 30, 2017 $62.03K
Rd Expense Q2 2019 · Sep 30, 2017 $126.41K
Net Income Q2 2019 · Sep 30, 2018 $4.21M
Net Income Q2 2019 · Sep 30, 2018 $8.83M
Net Income restated Q2 2019 · Sep 30, 2017 $2.31M
Net Income restated Q2 2019 · Sep 30, 2017 $6.23M
Operating Income Q2 2019 · Sep 30, 2018 $5.57M
Operating Income Q2 2019 · Sep 30, 2018 $11.7M
Operating Income Q2 2019 · Sep 30, 2017 $3.04M
Operating Income Q2 2019 · Sep 30, 2017 $7.68M
Gross Profit Q2 2019 · Sep 30, 2018 $8.07M
Gross Profit Q2 2019 · Sep 30, 2018 $16.99M
Gross Profit Q2 2019 · Sep 30, 2017 $5.06M
Gross Profit Q2 2019 · Sep 30, 2017 $11.9M
Cost Of Revenue Q2 2019 · Sep 30, 2018 $10.62M
Cost Of Revenue Q2 2019 · Sep 30, 2018 $22.58M
Cost Of Revenue Q2 2019 · Sep 30, 2017 $8.81M
Cost Of Revenue Q2 2019 · Sep 30, 2017 $19.1M
Revenue Q2 2019 · Sep 30, 2018 $18.68M
Revenue Q2 2019 · Sep 30, 2018 $39.57M
Revenue Q2 2019 · Sep 30, 2017 $13.87M
Revenue Q2 2019 · Sep 30, 2017 $31M